Certara

Guide

A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs

The FDA is phasing out animal testing of new drugs. Learn how Certara’s Non-Animal Navigator™…

CertaraNovember 17, 2025

Blog

From Insight to Impact: Certainty EMEA 2025

See how GenAI, unified digital trials, and a Totality of Evidence approach transform regulatory docs,…

CertaraNovember 17, 2025

Blog

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

Quantitative Systems Pharmacology (QSP) modeling tackles preclinical radiopharmaceuticals development challenges, from design to dose optimization.

CertaraNovember 14, 2025

Webinar

The Next Chapter: What Generative AI Means for Medical Writers [Korean Webinar]

CertaraNovember 14, 2025

Blog

Using M&S to Evaluate Oncology Drug Dosing

Learn how modeling & simulation improves oncology drug dosing, optimizing safety, efficacy, and personalized treatment…

CertaraNovember 14, 2025

Blog

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…

CertaraNovember 13, 2025

Webinar

Modern SDTM Starts Here: Metadata Management with P21 Enterprise Plus

CertaraNovember 13, 2025

Announcement

Certara and ANVISA Partner to Launch eCTD 4.0 Submissions of Drug Applications in Brazil Through GlobalSubmit™ software

Certara and ANVISA have joined forces to enable eCTD 4.0 submissions in Brazil using GlobalSubmit™…

CertaraNovember 13, 2025

Webinar

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

CertaraNovember 13, 2025

Publication

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

Certara and Ionis analyzed Phase 3 OASIS-HAE data showing flexible, effective donidalorsen dosing can reduce…

CertaraNovember 12, 2025

A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs

From Insight to Impact: Certainty EMEA 2025

Quantitative Systems Pharmacology Modeling to Support the Preclinical Development of Radiopharmaceuticals

The Next Chapter: What Generative AI Means for Medical Writers [Korean Webinar]

Using M&S to Evaluate Oncology Drug Dosing

ACoP 2025 Insights: Scaling the Future of QSP Modeling with Certara IQ™

Modern SDTM Starts Here: Metadata Management with P21 Enterprise Plus

Certara and ANVISA Partner to Launch eCTD 4.0 Submissions of Drug Applications in Brazil Through GlobalSubmit™ software

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

Newsletter sign up

Quick links

Solutions

Contact